×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Predictive Genetic Testing and Consumer Wellness Genomics Market Share

ID: MRFR/LS/9360-HCR
120 Pages
Rahul Gotadki
October 2025

Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, ... read more

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

ReportInfographic
Purchase Options

Market Share

Predictive Genetic Testing and Consumer Wellness Genomics Market Share Analysis

The predictive genetic testing and consumer wellness genomics industry have undergone tremendous expansion, driven by rising consumer interest in customized healthcare. Companies in this competitive industry are carefully positioning themselves to gain a considerable portion by delivering revolutionary genetic testing services that give insights into health concerns, heritage, and general wellbeing.

To appeal to a wide client base, corporations are broadening their genetic testing offerings. Beyond standard health risk evaluations, options also include ancestry testing, dietary analysis, and insights into fitness predispositions. This diversity draws a larger audience, placing organizations advantageously in the competitive environment. Market leaders are investing in the integration of modern genomic technologies. Adopting cutting-edge sequencing methods and bioinformatics tools boosts the quality and depth of genetic information offered to customers, providing enterprises a competitive advantage in offering complete and accurate genetic insights. Enhancing user experience is a primary emphasis in this business. Companies are creating user-friendly genetic testing kits and internet platforms, simplifying the sample collection procedure and delivering accessible and easy-to-understand findings. This method stimulates better customer participation and develops brand loyalty. Collaborations with healthcare providers are a deliberate effort to incorporate genetic testing into wider healthcare activities. Partnerships with clinics and hospitals enable firms to reach a larger audience, and the incorporation of genetic data into medical records helps more holistic healthcare management. Given the sensitive nature of genetic information, companies are prioritizing privacy and data security measures. Implementing powerful encryption, safe data storage, and explicit privacy rules generate confidence among customers, ensuring them that their genetic data is treated with the highest secrecy. Companies are launching initiatives to educate consumers about their genetic information. Educational material, webinars, and interactive platforms help customers make educated genetic testing decisions, increasing their value. Compliance with multiple regulatory systems helps companies develop abroad. Following international standards and securing regulatory clearances makes genetic testing services available to customers worldwide, increasing market share. Research and development are needed to advance genomics. Companies are investing in continuing investigations to uncover new genetic markers and connections to extend their testing services and provide customers the newest genetic information. Companies are using low prices and subscription schemes to entice more customers. Offering several levels of testing services with varied price points and subscription choices lets customers pick packages that fit their budget and tastes, expanding market penetration.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

Market Summary

Key Market Trends & Highlights

Market Trends

Predictive Genetic Testing and Consumer Wellness Genomics Market Market Drivers

Market Segment Insights

Regional Insights

Industry Developments

    • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
    • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
    • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
    • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
    • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.

Market Segmentation

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

By Test Type

  • Predictive Testing
  • Consumer Genomics
  • Wellness Genomics

North America

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

By Setting Type

  • Proteomic Testing
  • Metabolic Testing
  • Genomic Testing

Rest of the World

  • Middle East
  • Africa
  • Latin America 

By Application type

  • Breast & Ovarian Cancer
  • Cardiovascular Screening
  • Colon Cancer
  • Others

List of companies covered in this report:

  • 23andMe, Inc. (California)
  • Myriad Genetics, Inc. (US)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (US)
  • Genesis Genetics (US)
  • Agilent Technologies (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Bureau Gravimétrique International (China)
  • Bio-Rad Laboratories Inc. (US)
  • Illumina, Inc. (US)
  • Counsyl, Inc. (California)
  • ARUP Laboratories  (US)
  • Others

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments

  • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
  • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
  • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
  • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
  • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type

  • Wellness Genomics
  • Nutria Genetic
  • Skin & Metabolism Genetics
  • Others
  • Consumer Genomics
  • Predictive Testing
  • Genetic Susceptibility Test
  • Predictive Diagnostic
  • Population Screening

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application

  • Breast & Ovarian Cancer
  • Cardiovascular Screening
  • Diabetic Screening & Monitoring
  • Colon Cancer
  • Parkinsonism/Alzheimer’s Disease
  • Urologic Screening/Prostate Cancer Screening
  • Orthopedic & Musculoskeletal
  • Others

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type

  • Proteomic Testing
  • Metabolic Testing
  • Genomic Testing

Report Scope

Report Attribute/Metric Details
  Market Size   USD 11.2 Billion
  CAGR   5.4%
  Base Year   2022
  Forecast Period   2023-2032
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Test Type, Application, and Setting Type
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
  Key Vendors   23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US)
  Key Market Opportunities   Rise of application in personalized medicine
  Key Market Drivers   Usage of predictive genetic testing & consumer/wellness genomics in various applications

FAQs

How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

  1. EXECUTIVE SUMMARY
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
      1. Primary Interviews and Information Gathering Process
      2. Breakdown
    5. of Primary Respondents
    6. Forecasting Application
    7. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
    8. Data Triangulation
    9. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Porter’s Five Forces Analysis
    2. Threat of Substitutes
    3. on Supply Chain
  6. Bargaining Power of Suppliers
  7. Bargaining Power of Buyers
  8. Threat of New Entrants
  9. Intensity of Rivalry
    1. Value Chain Analysis
    2. COVID-19 Impact Analysis
      1. Market Impact Analysis
      2. Impact
      3. Regional Impact
      4. Opportunity and Threat Analysis
  10. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE
    2. Overview
    3. Predictive Testing
      1. Genetic
      2. Predictive Diagnostic
      3. Population Screening
    4. Susceptibility Test
    5. Consumer Genomics
    6. Wellness Genomics
      1. Nutria Genetic
      2. Skin & Metabolism Genetics
      3. Others
  11. GLOBAL PREDICTIVE
  12. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION
    1. Overview
    2. Breast & Ovarian Cancer
    3. Cardiovascular Screening
    4. Diabetic Screening & Monitoring
    5. Colon Cancer
    6. Parkinsonism/Alzheimer’s
    7. Disease
    8. Urologic Screening/Prostate Cancer Screening
    9. Orthopedic
    10. & Musculoskeletal
    11. Others
  13. GLOBAL PREDICTIVE GENETIC TESTING
  14. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE
    1. Overview
    2. Proteomic Testing
    3. Metabolic Testing
    4. Genomic Testing
  15. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY REGION
    1. Overview
    2. North America
      1. US
      2. Canada
      3. Germany
      4. France
      5. UK
      6. Italy
      7. Spain
      8. Rest of Europe
    3. Europe
    4. Asia-Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Australia
      6. Rest of Asia-Pacific
    5. Rest of the World
      1. Middle East
      2. Africa
      3. Latin America
  16. COMPANY LANDSCAPE
    1. Overview
    2. Competitive Analysis
    3. Market Share Analysis
    4. Major Growth Strategy in the Global Predictive Genetic Testing & Consumer/Wellness
    5. Genomics Market
    6. Competitive Benchmarking
    7. Leading Players in
    8. Terms of Number of Developments in the Global Predictive Genetic Testing & Consumer/Wellness
    9. Genomics Market
    10. Key developments and Growth Strategies
      1. New
      2. Merger & Acquisitions
    11. Product Launch/Service Deployment
    12. Joint Ventures
    13. Major Players
      1. Sales & Operating Income,
      2. Major Players R&D Expenditure. 2020
  17. COMPANY PROFILES
    1. 23andMe, Inc.
      1. Company Overview
      2. Financial Overview
      3. Products Offered
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    2. Myriad Genetics, Inc.
    3. F.Hoffmann-La
    4. Roche Ltd.
    5. Abbott Laboratories
    6. Genesis Genetics
    7. Agilent Technologies
    8. Thermo Fisher Scientific, Inc.
    9. Bureau
    10. Gravimétrique International
    11. Bio-Rad Laboratories Inc.
    12. Illumina, Inc.
    13. Counsyl, Inc.
    14. ARUP Laboratories
    15. Others
  18. APPENDIX
    1. References
    2. Related Reports
    3. LIST
  19. OF TABLES
  20. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    1. GENOMICS MARKET SYNOPSIS, 2023–2032
  21. GLOBAL PREDICTIVE GENETIC
    1. TESTING & CONSUMER/WELLNESS GENOMICS MARKET ESTIMATES & FORECAST, 2023–2032
    2. (USD MILLION)
  22. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  23. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  24. GLOBAL
  25. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  26. GLOBAL PREDICTIVE GENETIC TESTING &
  27. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  28. NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  29. MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  30. NORTH AMERICA:
  31. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  32. NORTH AMERICA: PREDICTIVE GENETIC TESTING
  33. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  34. US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE, 2023–2032 (USD MILLION)
  35. US: PREDICTIVE GENETIC
  36. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    1. (USD MILLION)
  37. US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  38. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  39. CANADA:
  40. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
  41. CANADA: PREDICTIVE GENETIC TESTING &
  42. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  43. CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY SETTING TYPE, 2023–2032 (USD MILLION)
  44. EUROPE: PREDICTIVE
  45. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
    1. (USD MILLION)
  46. EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  47. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  48. EUROPE:
  49. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
  50. GERMANY: PREDICTIVE GENETIC TESTING &
  51. CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  52. GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY APPLICATION, 2023–2032 (USD MILLION)
  53. GERMANY: PREDICTIVE GENETIC
  54. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  55. FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  56. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  57. FRANCE:
  58. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  59. FRANCE: PREDICTIVE GENETIC TESTING &
  60. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  61. ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE, 2023–2032 (USD MILLION)
  62. ITALY: PREDICTIVE GENETIC
  63. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    1. (USD MILLION)
  64. ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  65. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  66. SPAIN:
  67. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
  68. SPAIN: PREDICTIVE GENETIC TESTING &
  69. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  70. SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY SETTING TYPE, 2023–2032 (USD MILLION)
  71. UK: PREDICTIVE GENETIC
  72. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    1. MILLION)
  73. UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  74. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  75. UK: PREDICTIVE
  76. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  77. REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  78. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  79. REST
    1. OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
    2. APPLICATION, 2023–2032 (USD MILLION)
  80. REST OF EUROPE: PREDICTIVE
  81. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  82. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  83. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  84. ASIA-PACIFIC:
  85. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  86. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING
  87. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  88. JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE, 2023–2032 (USD MILLION)
  89. JAPAN: PREDICTIVE GENETIC
  90. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    1. (USD MILLION)
  91. JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  92. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  93. CHINA:
  94. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
  95. CHINA: PREDICTIVE GENETIC TESTING &
  96. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  97. CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY SETTING TYPE, 2023–2032 (USD MILLION)
  98. INDIA: PREDICTIVE GENETIC
  99. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    1. MILLION)
  100. INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  101. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  102. INDIA:
  103. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
  104. AUSTRALIA: PREDICTIVE GENETIC TESTING
  105. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  106. AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  107. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  108. AUSTRALIA: PREDICTIVE
  109. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  110. SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  111. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  112. SOUTH
  113. KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  114. SOUTH KOREA: PREDICTIVE GENETIC TESTING
  115. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  116. REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  117. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  118. REST
    1. OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    2. BY APPLICATION, 2023–2032 (USD MILLION)
  119. REST OF ASIA-PACIFIC:
  120. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
  121. REST OF THE WORLD: PREDICTIVE GENETIC
  122. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    1. MILLION)
  123. REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  124. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  125. REST
    1. OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    2. BY SETTING TYPE, 2023–2032 (USD MILLION)
  126. MIDDLE EAST: PREDICTIVE
  127. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
    1. (USD MILLION)
  128. MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  129. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  130. MIDDLE
  131. EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING
    1. TYPE, 2023–2032 (USD MILLION)
  132. AFRICA: PREDICTIVE GENETIC TESTING
  133. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  134. AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY APPLICATION, 2023–2032 (USD MILLION)
  135. AFRICA: PREDICTIVE GENETIC
  136. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  137. LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  138. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  139. LATIN
    1. AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
    2. APPLICATION, 2023–2032 (USD MILLION)
  140. LATIN AMERICA: PREDICTIVE
  141. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  142. LIST OF FIGURES
  143. RESEARCH PROCESS
    1. FIGURE 2
    2. MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  144. GENOMICS MARKET
  145. MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC
  146. TESTING & CONSUMER/WELLNESS GENOMICS MARKET
  147. GLOBAL PREDICTIVE
  148. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020
    1. (%)
  149. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  150. MARKET SHARE, BY APPLICATION, 2020 (%)
  151. GLOBAL PREDICTIVE GENETIC TESTING
  152. & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%)
    1. FIGURE
  153. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE,
    1. BY REGION, 2020 (%)
  154. NORTH AMERICA: PREDICTIVE GENETIC TESTING &
  155. CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
  156. EUROPE:
  157. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION,
  158. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  159. GENOMICS MARKET SHARE, BY REGION, 2020 (%)
  160. REST OF THE WORLD: PREDICTIVE
  161. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
  162. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET:
    1. COMPANY SHARE ANALYSIS, 2020 (%)
  163. 23ANDME, INC.: FINANCIAL OVERVIEW
    1. SNAPSHOT
  164. 23ANDME, INC.: SWOT ANALYSIS
  165. MYRIAD GENETICS,
    1. INC.: FINANCIAL OVERVIEW SNAPSHOT
  166. MYRIAD GENETICS INC.: SWOT ANALYSIS
  167. F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
    1. FIGURE 18
    2. F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
  168. ABBOTT LABORATORIES: FINANCIAL
    1. OVERVIEW SNAPSHOT
  169. ABBOTT LABORATORIES: SWOT ANALYSIS
    1. FIGURE
  170. GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT
  171. GENESIS GENETICS:
  172. SWOT ANALYSIS
  173. AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
  174. AGILENT TECHNOLOGIES: SWOT ANALYSIS
  175. THERMO FISHER SCIENTIFIC,
    1. INC.: FINANCIAL OVERVIEW SNAPSHOT
  176. THERMO FISHER SCIENTIFIC, INC.:
  177. SWOT ANALYSIS
  178. BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL
    1. OVERVIEW SNAPSHOT
  179. BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT
    1. ANALYSIS
  180. BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT
  181. BIO-RAD LABORATORIES INC..: SWOT ANALYSIS
  182. ILLUMINA, INC.:
    1. FINANCIAL OVERVIEW SNAPSHOT
  183. ILLUMINA, INC.: SWOT ANALYSIS
    1. FIGURE
  184. COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  185. COUNSYL, INC.: SWOT
    1. ANALYSIS
  186. ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
    1. FIGURE
  187. ARUP LABORATORIES: SWOT ANALYSIS

Predictive Genetic Testing & Consumer/Wellness Genomics Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions